Physician

Irene Andonia C Malaty, MD

According to 2025 Medicare claims, Irene Malaty, MD (NPI: 1134295694) practices neurology in the Gainesville, FL market, with the plurality of this provider's patient population coming from Alachua, FL. This provider's primary affiliated billing organization is FLORIDA CLINICAL PRACTICE ASSOCIATION INC (NPI: 1063463768; TIN: 59-1680273) and primary practice location at 32608-3928. Malaty is affiliated with the UF HEALTH ACO GAINESVILLE, LLC (ACO ID: A5468), participating under the MSSP model.

Malaty's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 350 traditional Medicare patients, billed 98,851 HCPCS/CPT codes, and received $594,714 in Medicare payments. The top billing code was 64616 (Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box). Part D data shows 629 prescription claims across 153 beneficiaries totaling $220,247 in drug costs, led by Austedo (Deutetrabenazine). 2020 DME data shows 21 claims. Open Payments data shows 10 records totaling $68,427. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $93,585 to $594,714. In contrast, Part D prescription costs have fallen sharply in recent years, from $267,139 to $220,247. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	472	1,113	$93,585
2016	508	1,457	$121,652
2017	406	1,279	$99,751
2018	391	1,211	$93,263
2019	399	1,216	$91,116
2020	362	3,135	$86,554
2021	327	24,886	$206,849
2022	361	106,958	$653,736
2023	392	91,627	$557,599
2024	350	98,851	$594,714

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	244	1,201	$267,139
2016	298	1,606	$660,815
2017	285	1,637	$895,826
2018	260	1,553	$737,571
2019	218	1,293	$358,880
2020	166	771	$436,759
2021	103	371	$420,003
2022	125	518	$191,045
2023	143	575	$222,420
2024	153	629	$220,247

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	67	$134,435
2017	N/R	58	$149,630
2018	N/R	38	$186,384
2019	N/R	80	$247,414
2020	N/R	21	$168,375
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
64616	Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box	77	210	$144
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	141	166	$89
95874	Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle	98	259	$56
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	152	172	$12
J0585	Injection, onabotulinumtoxina, 1 unit	113	90,455	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Austedo	Deutetrabenazine	22	780	$157,805
Rytary	Carbidopa/Levodopa	16	755	$19,022
Carbidopa	Carbidopa	11	1,010	$7,409
Carbidopa-Levodopa	Carbidopa/Levodopa	114	9,240	$7,111
Carbidopa-Levodopa Er	Carbidopa/Levodopa	39	3,340	$1,773

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	8	$6,820	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	2	$61,607	Sage Therapeutics, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Irene Andonia C. Malaty, MD?

Tedicare shows public-source Medicare data for Irene Andonia C. Malaty, MD (NPI 1134295694), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Irene Andonia C. Malaty, MD have ACO affiliation data?

Irene Andonia C. Malaty, MD is shown with ACO affiliation data for UF HEALTH ACO GAINESVILLE, LLC (MSSP, ACO ID A5468).

What billing organization is linked to Irene Andonia C. Malaty, MD?

Irene Andonia C. Malaty, MD is linked to FLORIDA CLINICAL PRACTICE ASSOCIATION INC (billing NPI 1063463768) in the available physician profile data.

Does Irene Andonia C. Malaty, MD have Open Payments data?

Irene Andonia C. Malaty, MD has 10 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.